Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page has been updated to include the term 'Renal Cell Carcinoma (RCC)' and the EudraCT number for the study, while significant details about the study's purpose, inclusion and exclusion criteria, and previous revision information have been removed.SummaryDifference10%
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.SummaryDifference0.2%
- Check27 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.SummaryDifference0.2%
- Check35 days agoChange DetectedThe web page has updated its date-related content, adding new dates in March and June 2025 while removing older dates from January and February 2025.SummaryDifference0.6%
- Check57 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check78 days agoChange DetectedThe webpage has updated its service availability information, indicating that some NLM-NCBI services are experiencing heavy traffic, which may impact performance. Additionally, several dates have been updated to reflect future timelines.SummaryDifference2%
Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.